Vimarsana
Biggest News Aggregation in the World

Molecular Sciencesstudy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Molecular Sciencesstudy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Molecular Sciencesstudy Today - Breaking & Trending Today

Does breast milk influence infants' intestinal microbiota? - Vimarsana News

Does breast milk influence infants' intestinal microbiota?

A large number of health-related benefits of probiotics have led to the development of a new discipline called probiogenomics, which focuses on the molecular mechanisms of probiotic activities. According to the US Food and Drug Administration (FDA), the next-generation probiotics satisfy the scope of "live biotherapeutic products" (LBPs), which could be used to develop effective therapeutics for various diseases.

SARS-CoV-2 'Deltacron' variant exhibits immune-escape properties similar to Omicron BA.1 - Vimarsana News

SARS-CoV-2 'Deltacron' variant exhibits immune-escape properties similar to Omicron BA.1

The SARS-CoV-2 Deltacron does not exhibit higher transmissibility or immune evasion than the Omicron BA.1 variant.

What is the efficacy of mulberry component Kuwanon C against COVID-19? - Vimarsana News

What is the efficacy of mulberry component Kuwanon C against COVID-19?

A recent study determined the underlying antiviral mechanism of KC associated with the inhibition of SARS-CoV-2.

Lipids in breastmilk may protect against metabolic disease later in life - Vimarsana News

Lipids in breastmilk may protect against metabolic disease later in life

A new study examines the lipid content in breastmilk and its association with NCDs later in life.

COVID-19 may affect a group of biochemical reactions called one-carbon metabolism - Vimarsana News

COVID-19 may affect a group of biochemical reactions called one-carbon metabolism

A new study addresses the relationship between SARS-CoV-2 to the metabolism of one-carbon molecules in the host, suggesting new therapeutic pathways.